Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Open-label, Uncontrolled Study to Assess Contraceptive Efficacy and Safety of Mirena During Extended Use Beyond 5 Years in Women 18 to 35 Years of Age Including a Subgroup Evaluation of Treatment Effect on Heavy Menstrual Bleeding

NCT02985541 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02985541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02985541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Open-label, Uncontrolled Study to Assess Contraceptive Efficacy and Safety of Mirena During Extended Use Beyond 5 Years in Women 18 to 35 Years of Age Including a Subgroup Evaluation of Treatment Effect on Heavy Menstrual Bleeding
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
December 22, 2016
Completion date
May 28, 2021
Enrollment
364 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

contraception